CN113930449B - Drosophila larva tissue organ in-situ plasmid transfection method - Google Patents
Drosophila larva tissue organ in-situ plasmid transfection method Download PDFInfo
- Publication number
- CN113930449B CN113930449B CN202111111905.2A CN202111111905A CN113930449B CN 113930449 B CN113930449 B CN 113930449B CN 202111111905 A CN202111111905 A CN 202111111905A CN 113930449 B CN113930449 B CN 113930449B
- Authority
- CN
- China
- Prior art keywords
- transfection
- solution
- drosophila
- tissue
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 title claims abstract description 53
- 210000000056 organ Anatomy 0.000 title claims abstract description 45
- 239000013612 plasmid Substances 0.000 title claims abstract description 30
- 238000011065 in-situ storage Methods 0.000 title claims abstract description 13
- 238000003151 transfection method Methods 0.000 title claims abstract description 13
- 238000001890 transfection Methods 0.000 claims abstract description 66
- 239000000243 solution Substances 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000000694 effects Effects 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000011259 mixed solution Substances 0.000 claims abstract description 7
- 238000001514 detection method Methods 0.000 claims abstract description 4
- 238000003306 harvesting Methods 0.000 claims abstract description 4
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims abstract description 4
- 238000003125 immunofluorescent labeling Methods 0.000 claims abstract description 3
- 210000001519 tissue Anatomy 0.000 claims description 41
- 239000008055 phosphate buffer solution Substances 0.000 claims description 24
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 16
- 238000004140 cleaning Methods 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 12
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 9
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 9
- 239000001540 sodium lactate Substances 0.000 claims description 9
- 229940005581 sodium lactate Drugs 0.000 claims description 9
- 235000011088 sodium lactate Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 229940054269 sodium pyruvate Drugs 0.000 claims description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 7
- 239000010413 mother solution Substances 0.000 claims description 7
- 210000003079 salivary gland Anatomy 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 210000004556 brain Anatomy 0.000 claims description 6
- 239000012194 insect media Substances 0.000 claims description 6
- 239000011550 stock solution Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- LTMHDMANZUZIPE-UHFFFAOYSA-N 3-[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one Chemical compound C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 4
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- 239000003344 environmental pollutant Substances 0.000 claims description 4
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 claims description 4
- 108010052968 leupeptin Proteins 0.000 claims description 4
- 229940049954 penicillin Drugs 0.000 claims description 4
- 108010091212 pepstatin Proteins 0.000 claims description 4
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 claims description 4
- 231100000719 pollutant Toxicity 0.000 claims description 4
- 229960005322 streptomycin Drugs 0.000 claims description 4
- 108010039627 Aprotinin Proteins 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 229960004405 aprotinin Drugs 0.000 claims description 3
- 210000003169 central nervous system Anatomy 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 239000012091 fetal bovine serum Substances 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims description 3
- 229950000964 pepstatin Drugs 0.000 claims description 3
- 241000255601 Drosophila melanogaster Species 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 4
- 241000255588 Tephritidae Species 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 3
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 238000003153 stable transfection Methods 0.000 abstract description 2
- 238000011534 incubation Methods 0.000 abstract 1
- 238000011533 pre-incubation Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 4
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108010001515 Galectin 4 Proteins 0.000 description 2
- 102100039556 Galectin-4 Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000001418 larval effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000005293 physical law Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/103—Plasmid DNA for invertebrates
- C12N2800/105—Plasmid DNA for invertebrates for insects
Abstract
The invention discloses an in-situ plasmid transfection method for tissues and organs of Drosophila larvae, and relates to the technical field of biology. The method comprises the following steps: s1, preparing tissues and organs to be transfected of Drosophila larvae; s2 transfection: transferring the Drosophila tissue and organ to a 96-hole culture dish, performing transfection on the mixed solution A after incubation and transfection in sequence, performing stable transfection on the pre-incubation culture solution B, and performing conventional culture on the transfected tissue and organ by using the whole culture solution C; s3 transfection detection: and (3) harvesting the tissue and organ transfected in the step (S2), fixing the tissue and organ by formaldehyde, and observing the transfection effect by adopting conventional immunofluorescence staining. The invention can directly transfect the fruit fly larva tissue organ, and the transfection and successful expression of exogenous genes can be observed in 48 hours, and the technical scheme is implemented by a 12-hour liquid change rule, and the fruit fly tissue organ is cultured at 25 ℃, so that the proliferation speed of microbial contamination can not reach the pollution degree, and the method is suitable for a bacterial operation environment.
Description
Technical Field
The invention relates to the technical field of biology, in particular to an in-situ plasmid transfection method for tissues and organs of Drosophila larvae.
Background
Transfection (transfection) is the process of introducing exogenous DNA or RNA fragments actively or passively into cells in vitro or in vivo by corresponding biotechnological treatment, followed by protein expression or obtaining a new phenotype in the cells (e.g., RNAi). Conventional transfection techniques can be classified as transient transfection, in which exogenous DNA/RNA is not integrated into the host chromosome, and in which multiple copies of nucleic acid can be present simultaneously, and thus are high in expression levels and usually only maintain expression for several days, and stable transfection, in which exogenous DNA can be integrated into the host chromosome or possibly exist as episome.
Modern transfection methods are divided into: chemical, physical and viral transfection methods. Wherein the chemical method comprises the following steps: calcium phosphate method, DEAE-dextran method, liposome method, etc.; the physical method comprises the following steps: microinjection, electroporation, and gene gun; the chemical method is used for removing the calcium phosphate method, other types are required to use commercial transfection reagents, and the reagents have high cost of single transfection due to high price and large dosage, and in addition, the commercial transfection reagents can only be used for transfecting cell-level samples and are ineffective for tissues; while the physical laws require expensive instruments such as microinjection instruments, electrotransfection instruments, gene guns, and the like; the virus transfection method needs commercialized virus or self-packaging virus, has complicated operation flow, and the existing adenovirus transfection vector and the like are ineffective to drosophila cell tissues.
Meanwhile, in the prior art, the conventional transfection process generally only operates on cell-grade samples in a growing period, so that a high-standard sterile cell culture environment is required, and the conventional transfection process is almost ineffective on mutant cell strains with poor proliferation and division capacity and large tissue masses, and further increases the transfection cost.
Disclosure of Invention
The invention provides an in-situ plasmid transfection method for tissues and organs of Drosophila larvae, which aims to solve the problems in the background technology.
In order to achieve the technical purpose, the invention mainly adopts the following technical scheme:
an in-situ plasmid transfection method for a Drosophila larva tissue organ comprises the following steps:
s1, preparing tissues and organs of Drosophila larvae: taking a plurality of Drosophila larvae as a group, repeatedly cleaning the Drosophila larvae in PBST for a plurality of times to remove dirt and pollutants outside the body surface, then dripping sterilizing PBS (phosphate buffer solution) cleaning solution into a culture dish, dissecting the Drosophila larvae in the cleaning solution, avoiding damaging intestinal tracts as much as possible, causing the outflow of contents to pollute, and intercepting the upper sections of the Drosophila larvae, including eyes, wings, legs, balance bars, brain, central nervous system, salivary glands and attached epidermis;
the three-instar larvae of Drosophila under common feeding conditions can be used in the experiment, and the probability of accidental pollution can be reduced by feeding under aseptic or bacteria-reducing conditions.
S2 transfection: transferring the tissues and organs of the drosophila melanogaster into a 96-hole culture dish, adding the transfection mixed solution A, and carrying out slow transfection on a shaking table; then sucking the transfection mixture A, using PBS for rapid cleaning, adding the preculture solution B, and culturing for 4-6 hours at 25 ℃; the preculture solution B is replaced by the whole culture solution C for culture; typically, less than 5 larval tissue organs per well can be cultured and transfected;
s3 transfection detection: harvesting the tissue and organ transfected in the step S2, fixing the tissue and organ with formaldehyde, and observing the transfection effect by adopting conventional immunofluorescence staining;
the preparation method of the transfection mixed solution A comprises the following steps: adding 1ul of 5% digitalis glycoside concentrated stock solution and 200ng of plasmid to be transfected into 100ul of transfection mixed liquor mother solution, wherein the main body of the transfection mixed liquor mother solution is SHIELDS AND SANG M INSTCT MEDIUM INSECT culture MEDIUM, 10ul of 200mM glutamine, 2ul of 60% sodium lactate and 10ul of 100mM sodium pyruvate are added into each 1ml of culture MEDIUM, and in addition, 1ug of pepstatin, 10ug of aprotinin and 1ug of leupeptin are also added into each 1ml of transfection mixed liquor mother solution;
subpackaging insect culture medium into 1ml and storing sodium pyruvate in a concentrated way at-20deg.C for freezing, and dissolving to room temperature before use; the concentrated liquid of glutamine and three protease inhibitors is frozen and packaged and stored at-80 ℃, and is stored to-20 ℃ in a small amount when being temporarily used, and is used within one month and is discarded after expiration; preserving 60% sodium lactate storage solution at 4 ℃;
the digitalis glycoside concentrated stock solution is preserved to the condition of-80 ℃ and is effective at-20 ℃ for 3 months;
the preparation method of the preculture solution B comprises the following steps: 200ng of plasmid to be transfected was added to 100ul SHIELDS AND SANG M3INSECT MEDIUM insect medium;
the preparation method of the whole culture solution C comprises the following steps: to a main body of SHIELDS AND SANG M3.sup.3 INSTECT MEDIUM INSECT MEDIUM, 10ul 200mM glutamine, 2ul 60% sodium lactate, 10ul 100mM sodium pyruvate, 10ul 100X (preferably at a defined concentration, the concept of this ambiguity is not allowed in the patent) of penicillin and streptomycin double anti-concentrate stock and 100ul fetal bovine serum are added per 900ul MEDIUM.
The whole culture solution is placed in a refrigerator at 4 ℃ and is balanced to room temperature before use, and then is placed back for cold storage after use.
In the invention, in the step S1, the number of the Drosophila larvae in each group is not more than 5, the surfaces of the Drosophila larvae are repeatedly washed for 3 times by using PBST, and the Drosophila larvae are dissected in a culture dish containing sterilized PBS.
In the step S2, the dissected drosophila tissue and organ is quickly washed twice with PBS, and each washing process is as follows: after washing with PBS wash liquid for 10 times and washing and transferring the tissue and organ twice, the forceps were flame sterilized and cooled in air for use.
The specific operation can be as follows: and (3) dropwise adding 10 drops of PBS into the culture dish, wherein each drop is about 60-80ul, after dissection is completed, each tissue and organ of the drosophila larva is gradually cleaned, so that possible pollutants on the surface and in gaps of each tissue and organ of the drosophila larva are cleaned as much as possible, the drosophila larva is sterilized and cooled by using a tweezer alcohol burner flame for operation, and the tweezer needs to be sterilized once after every two drops of cleaning.
Further, the preparation method of the sterilized PBST cleaning solution is to add 100ul of TritonX100 to 100ml of PBS.
In the invention, the PBS is prepared according to the following proportion: taking 0.27g of monopotassium phosphate, 1.42g of disodium hydrogen phosphate, 8g of sodium chloride and 0.2g of potassium chloride, adding about 800mL of deionized water, fully stirring and dissolving, then adding concentrated hydrochloric acid to adjust the pH to 7.4, finally fixing the volume to 1L, sterilizing at the high temperature of 121 ℃ for 20 minutes, and cooling for later use.
Preferably, in the step S2, the amount of the transfection mixture A is at least 50ul, and the slow transfection time on a shaker is 30min-1h.
Preferably, in the step S2, the whole culture solution C is used for changing the solution once every 12 hours, and the solution is changed at least 3 times, so that the total culture time of the whole culture solution C is ensured to reach 48 hours, and the whole culture solution C is washed with PBS at room temperature at least once every time of changing the solution.
Further, in the step S2, the transfection solution A was mixed with the preculture solution B to transfect Arm-Gal4 100ng and UAS-GPI-GFP 100ng plasmids, and the total mass of the transfected plasmids was 200ng.
Compared with the prior art, the invention has the following beneficial effects:
1. the invention uses chemical cell membrane perforation agent digitalis glycoside (digitonin) to assist in directly perforating and penetrating the cell membrane and nuclear membrane of the tissues and organs of the Drosophila larva by other protease inhibition and auxiliary culture reagents, so that the plasmid to be expressed directly permeates into the cell nucleus for expression without relying on cell division for transfection expression, thus being applicable to cell lines and Drosophila strains with proliferation and division disorder, and being capable of carrying out tissue organ level transfection of the Drosophila larva without being digested into single cells;
2. in the culture medium, energy metabolism substances of glutamine, pyruvic acid and sodium lactate are added, so that the activity of the tissue cells of the Drosophila larvae is enhanced, and plasmid expression is facilitated;
3. the added intermediate liquid change steps enable the method to be applied to a fungus environment, so that the application range of the application is greatly improved, and the environmental cost is reduced;
4. the pre-culture solution B is added, so that the plasmid transfection and infiltration effect can be enhanced;
5. the invention has higher transfection efficiency, the average transfection efficiency of the adult disc and the brain is improved by 1/3, and the average transfection efficiency of salivary glands is improved by 2/3 according to immunofluorescence detection;
6. the cost is low, the price of the whole set of reagent is about 5000 yuan, but the sample can be transfected by more than 5000 yuan.
Drawings
FIG. 1 shows the brain organs of Drosophila larvae after 48 hours of transfection in the present invention;
FIG. 2 is an enlarged schematic view of portion A of FIG. 1;
FIG. 3 shows the transfection effect of Drosophila larvae salivary glands.
Detailed Description
The above-described matters of the present invention will be further described in detail by way of examples, but it should not be construed that the scope of the above-described subject matter of the present invention is limited to the following examples, and all techniques realized based on the above-described matters of the present invention are within the scope of the present invention.
Examples
PBS buffer was prepared: taking potassium dihydrogen phosphate (KH 2PO 4): 0.27g, disodium hydrogen phosphate (Na 2HPO 4): 1.42g, sodium chloride (NaCl): 8g of potassium chloride (KCl) 0.2g, adding about 800mL of deionized water, fully stirring and dissolving, then adding concentrated hydrochloric acid to adjust the pH to 7.4, finally fixing the volume to 1L, sterilizing at the high temperature of 121 ℃ for 20 minutes, and cooling for later use.
Preparing a sterilized PBST cleaning solution: 100ul TritonX100 was added to 100ml PBS buffer.
Preparing a transfection mixed solution mother solution: the main body was SHIELDS AND SANG M INSTECT MEDIUM INSECT MEDIUM (Sigma), 10ul of glutamine (200 mM), 2ul of sodium lactate (60%), 10ul of sodium pyruvate (100 mM) were added per 1ml of MEDIUM, and 1ug of Pepstatin (Pepstatin A), 10ug of Aprotinin (Aprotin) and 1ug of Leupeptin (Leupeptin) were added per ml of mother liquor. Subpackaging the culture medium into 1ml and concentrating sodium pyruvate for storage at-20deg.C, and dissolving to room temperature before use. The concentrated liquid of glutamine and three protease inhibitors is frozen and packaged and stored at-80 ℃, and is stored to-20 ℃ in a small amount when being temporarily used, and is used within one month and is discarded after expiration. 60% sodium lactate stock solution was stored at 4 ℃.
Preparing transfection mixed solution A:100ul of transfection mixture stock O+1ul 5% digitonin stock (digitonin) +200 ng of total amount of plasmid to be transfected, digitonin stock is stored at-80℃for 3 months to be effective at-20 ℃. In this case, the transfection-driven plasmids Arm-Gal4 and UAS-GPI-GFP were each 100ng.
Preparation of preculture solution B:100ul SHIELDS AND SANG M3INSECT MEDIUM insect medium+200 ng total plasmid to be transfected.
Preparing a whole culture solution C: the main body is SHIELDS AND SANG M INSTECT MEDIUM INSECT culture MEDIUM, and 10ul glutamine (200 mM), 2ul sodium lactate (60%), 10ul sodium pyruvate (100 mM), 10ul penicillin streptomycin double anti-concentrated stock solution (100X) and 100ul fetal bovine serum are added into each 900ul of culture MEDIUM.
An in-situ plasmid transfection method for a Drosophila larva tissue organ comprises the following steps:
1. the three-instar larvae of Drosophila under common feeding conditions can be used in the experiment, and the probability of accidental pollution can be reduced by feeding under aseptic or bacteria-reducing conditions.
2. About 10 three-year-old Drosophila larvae are taken into a sterilized PBST cleaning solution containing 0.1% TritonX-100, and the surfaces are cleaned for 3 times, so that no obvious dirt is ensured.
3. And the sterilizing PBS cleaning solution is used for dissecting the Drosophila larvae, so that intestinal tracts are prevented from being damaged as much as possible, and the outflow of the content causes pollution. The upper segment of Drosophila larvae, including the tissues and organs of eyes, wings, legs, balance bars, brain and central nervous system, salivary glands, and the epidermis to which they are attached, is intercepted. 10 drops of PBS are dripped into the culture dish, each drop is about 60-80ul, the washing is carried out drop by drop, and possible pollutants on the surfaces and gaps of the tissues and organs are washed as much as possible. The alcohol lamp flame disinfection and cooling operation is carried out on tweezers, and the alcohol lamp is used after being disinfected once every two drops are transferred.
4. The cleaned Drosophila tissue organs were transferred to 96-well petri dishes, and less than 5 larva tissue organs were cultured and transfected per well. 50ul of the transfection mixture A is added, and the mixture is slowly transfected on a shaking table for 30min-1h.
5. The transfection mixture A was blotted and rapidly washed 2 times with 100ul of PBS for several seconds.
6. The PBS is sucked and added into the preculture solution B for culturing for 4 to 6 hours at 25 ℃.
7. The solution was changed to 200. Mu.l of the whole culture solution C, and then the solution was changed every 12 hours, and the solution was washed with PBS at room temperature to reduce the possibility of subsequent contamination. The whole culture solution is placed in a refrigerator at 4 ℃ and is balanced to room temperature before use, and then is placed back for cold storage after use. The liquid is exchanged for 3 times, so that the culture time reaches more than 48 hours.
8. Harvesting tissue and organ, fixing by formaldehyde, staining by conventional immunofluorescence, and observing transfection effect.
Test examples
According to the transfection method of the embodiment of the invention, the corresponding transfection effect monitoring is carried out on the tissue trachea of the Drosophila larvae.
As shown in FIG. 1, the Drosophila larval brain organs 48 hours after transfection, the cells of the two-optic bulb part (circular enlargement) showed a general membrane-localized GFP expression. Two plasmids, one of which is an expression driving plasmid, armadillio-Gal 4, which has ubiquitous expression characteristics and can express binary expression driving factor Gal4 after almost all cells are accepted; another plasmid is UAS-GPI-GFP, and binding of driver Gal4 to regulatory element 5 XUAS induces GPI-GFP expression in large amounts, GPI-GFP being a cell membrane-localized GFP with phosphatidylinositol anchoring domains, displaying more cell contours than nuclear-localized or cytoplasmic localized GFP and facilitating differentiation of transfected cells.
FIG. 2 is an enlarged portion of the image shown within the box of the white dashed line in FIG. 1, showing that a large number of cells exhibiting circular membrane localized transfection success were observed.
FIGS. 3B and B' show transfection effect of Drosophila larvae salivary glands, the transfection effect is stable, and cells with no outline of green fluorescent cell membrane in the image are untransfected functional cells, which can keep over 2/3 of cells successfully transfected and expressed.
The transfection method can directly transfect tissues and organs of the Drosophila larvae, and can observe that the tissues and organs of the adult disc, brain, salivary glands and the like of the Drosophila achieve transfection and successful expression of exogenous genes in 48 hours. Because the technical proposal is implemented for 12 hours with regular liquid exchange, and the fruit fly tissue and organ culture is 25 ℃, the proliferation speed of microbial contamination can not reach the pollution degree, so the technology is suitable for the bacterial operation environment without the operation among cells.
The above embodiment is only one of the preferred embodiments of the present invention, and should not be used to limit the scope of the present invention, but all the insubstantial modifications or color changes made in the main design concept and spirit of the present invention are still consistent with the present invention, and all the technical problems to be solved are included in the scope of the present invention.
Claims (6)
1. The in-situ plasmid transfection method for the tissues and organs of the Drosophila larvae is characterized by comprising the following steps of:
s1, preparing tissues and organs to be transfected by Drosophila larvae: taking a plurality of Drosophila larvae as a group, repeatedly cleaning the Drosophila larvae in PBST for a plurality of times to remove dirt and pollutants outside the body surface, then dripping sterilizing PBS (phosphate buffer solution) cleaning solution into a culture dish, dissecting the Drosophila larvae in the cleaning solution, avoiding damaging intestinal tracts as much as possible, causing the outflow of contents to pollute, and intercepting the upper sections of the Drosophila larvae, including eyes, wings, legs, balance bars, brain, central nervous system, salivary glands and attached epidermis;
s2 transfection: transferring the tissues and organs of the drosophila melanogaster into a 96-hole culture dish, adding the transfection mixed solution A, and carrying out slow transfection on a shaking table; then sucking the transfection mixture A, using PBS for rapid cleaning, adding the preculture solution B, and culturing for 4-6 hours at 25 ℃; the preculture solution B is replaced by the whole culture solution C for culture;
s3 transfection detection: harvesting the tissue and organ transfected in the step S2, fixing the tissue and organ with formaldehyde, and observing the transfection effect by adopting conventional immunofluorescence staining;
the preparation method of the transfection mixed solution A comprises the following steps: adding 1ul of 5% digitalis glycoside concentrated stock solution and 200ng of plasmid to be transfected into 100ul of transfection mixed liquor mother solution, wherein the main body of the transfection mixed liquor mother solution is SHIELDS AND SANG M INSTCT MEDIUM INSECT culture MEDIUM, 10ul of 200mM glutamine, 2ul of 60% sodium lactate and 10ul of 100mM sodium pyruvate are added into each 1ml of culture MEDIUM, and in addition, 1ug of pepstatin, 10ug of aprotinin and 1ug of leupeptin are also added into each 1ml of transfection mixed liquor mother solution;
the preparation method of the preculture solution B comprises the following steps: 200ng of plasmid to be transfected was added to 100ul SHIELDS AND SANG M3INSECT MEDIUM insect medium;
the preparation method of the whole culture solution C comprises the following steps: to a main body of SHIELDS AND SANG M3.sup.3 INSTECT MEDIUM INSECT MEDIUM, 10ul 200mM glutamine, 2ul 60% sodium lactate, 10ul 100mM sodium pyruvate, 10ul penicillin and streptomycin double anti concentrate stock solution and 100ul fetal bovine serum were added per 900ul MEDIUM, wherein the penicillin concentration was 10000U/ml and the streptomycin concentration was 10mg/ml.
2. The method for in situ plasmid transfection of Drosophila larva tissue organs according to claim 1, wherein: in step S1, the number of Drosophila larvae in each group is not more than 5, the surfaces of the Drosophila larvae are repeatedly washed 3 times by PBST, and dissected in a culture dish containing sterilized PBS.
3. The method for in situ plasmid transfection of Drosophila larva tissue organs according to claim 1, wherein: in the step S2, the dissected drosophila tissue and organ is quickly washed 2 times with PBS, and each washing process is as follows: after washing with PBS wash liquid for 10 times and washing and transferring the tissue and organ twice, the forceps were flame sterilized and cooled in air for use.
4. The method for in situ plasmid transfection of Drosophila larva tissue organs according to claim 1, wherein: in the step S2, the addition amount of the transfection mixture A is at least 50ul, and the slow transfection time on a shaking table is 30min-1h.
5. The method for in situ plasmid transfection of Drosophila larva tissue organs according to claim 1, wherein: in the step S2, the whole culture solution C is used for changing the solution once every 12 hours, and the solution is changed at least 3 times, so that the total culture time of the whole culture solution C is ensured to reach 48 hours, and the whole culture solution C is washed at least once by using room temperature PBS every time of the solution change.
6. The method for in situ plasmid transfection of Drosophila larva tissue organs according to claim 1, wherein: in the step S2, the transfection solution A and the preculture solution B are mixed to transfect Arm-Gal4 100ng and UAS-GPI-GFP 100ng plasmids, and the total mass of the transfected plasmids is 200ng.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111111905.2A CN113930449B (en) | 2021-09-23 | 2021-09-23 | Drosophila larva tissue organ in-situ plasmid transfection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111111905.2A CN113930449B (en) | 2021-09-23 | 2021-09-23 | Drosophila larva tissue organ in-situ plasmid transfection method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113930449A CN113930449A (en) | 2022-01-14 |
CN113930449B true CN113930449B (en) | 2024-02-02 |
Family
ID=79276472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111111905.2A Active CN113930449B (en) | 2021-09-23 | 2021-09-23 | Drosophila larva tissue organ in-situ plasmid transfection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113930449B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999029845A1 (en) * | 1997-12-09 | 1999-06-17 | Commissariat A L'energie Atomique | SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS |
JP2001157588A (en) * | 1999-12-02 | 2001-06-12 | Osaka Bioscience Institute | Gene trap using green fluorescent protein |
CN1365392A (en) * | 1999-07-21 | 2002-08-21 | 犹太大学阿尔伯特爱因斯坦医学院 | Drosophila recombination-associated protein and methods for use |
CN101082045A (en) * | 2007-01-22 | 2007-12-05 | 耿永健 | Preparation method of apolipoprotein-J |
CN103096932A (en) * | 2010-06-14 | 2013-05-08 | 弗·哈夫曼-拉罗切有限公司 | Cell-penetrating peptides and uses therof |
CN106755093A (en) * | 2016-11-30 | 2017-05-31 | 中山汉腾生物科技有限公司 | The technique that drosophila cell is transiently transfected |
-
2021
- 2021-09-23 CN CN202111111905.2A patent/CN113930449B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999029845A1 (en) * | 1997-12-09 | 1999-06-17 | Commissariat A L'energie Atomique | SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS |
CN1365392A (en) * | 1999-07-21 | 2002-08-21 | 犹太大学阿尔伯特爱因斯坦医学院 | Drosophila recombination-associated protein and methods for use |
JP2001157588A (en) * | 1999-12-02 | 2001-06-12 | Osaka Bioscience Institute | Gene trap using green fluorescent protein |
CN101082045A (en) * | 2007-01-22 | 2007-12-05 | 耿永健 | Preparation method of apolipoprotein-J |
CN103096932A (en) * | 2010-06-14 | 2013-05-08 | 弗·哈夫曼-拉罗切有限公司 | Cell-penetrating peptides and uses therof |
CN106755093A (en) * | 2016-11-30 | 2017-05-31 | 中山汉腾生物科技有限公司 | The technique that drosophila cell is transiently transfected |
Non-Patent Citations (1)
Title |
---|
磷脂酰乙醇胺N-甲基转移酶2过表达对大鼠肝癌细胞不同亚型蛋白激酶C表达及转位的影响;李亚丽, 马克里, 邹伟, 夏泉, 崔肇春;中华肝脏病杂志(09);43-46 * |
Also Published As
Publication number | Publication date |
---|---|
CN113930449A (en) | 2022-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230272346A1 (en) | Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure | |
CN107190006A (en) | A kind of sgRNA of targeting IGF IR genes and its application | |
Nema et al. | An animal cell culture: Advance technology for modern research | |
CN103173403B (en) | Split-range embryo culture solution and preparation method thereof | |
Freed et al. | Culture methods for anuran cells | |
NO851165L (en) | DOOR IDENTIFICATION SYSTEM IN MINIATURE SCALE | |
Seth | Freezing mammalian cells for production of biopharmaceuticals | |
Rothstein | Experimental techniques for investigation of the amphibian lens epithelium | |
US8551780B2 (en) | Electroporation buffer composition and method of use | |
CN105483078A (en) | Isolation and primary culture methods of chicken small intestinal epithelial cells | |
CN113930449B (en) | Drosophila larva tissue organ in-situ plasmid transfection method | |
Steinberger et al. | In vitro growth and development of mammalian testes | |
Harnden et al. | The skin culture technique | |
JP2022502047A (en) | Methods of isolation and culture of human retinal progenitor cells | |
Hood et al. | Isolation, culture, and cryosectioning of primary porcine retinal pigment epithelium on transwell cell culture inserts | |
CA2098498A1 (en) | Particle-mediated transformation of mammalian unattached cells | |
US20080268542A1 (en) | High Efficiency Electroporation Buffer | |
CN101974565B (en) | Method for producing transgenic buffalo embryos by applying intracytoplasmic sperm injection (ICSI) mediation | |
CN114908032A (en) | Preparation, culture, cryopreservation and resuscitation method and application of testicular-like organ | |
Nault et al. | Dissociated hippocampal cultures | |
Hasan et al. | Ex vivo expansion of primary cells from limb tissue of Pleurodeles waltl | |
Takahashi et al. | Gene transfer into cultured mammalian embryos by electroporation | |
Schneider | Cultivation of dipteran cells in vitro | |
Saxe et al. | General cell culture principles and fibroblast culture | |
Varma et al. | Methods in mosquito cell culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |